SNIBE Maglumi X3 or HumaCLIA 150: Which Immunoassay Analyzer To Choose?

Chemiluminescence immunoassay (CLIA) analyzers such as the HumaCLIA 150 and Maglumi X3 offer advanced features and capabilities to meet the diverse needs of today's diagnostic laboratories. Understanding the specific benefits of each model can help you select the optimal instrument for your laboratory's needs.

 

Company HUMAN SNIBE
Model HumaCLIA 150 Maglumi X3
Type of Instrument Benchtop Benchtop
Mode Continuous access Continuous access
Detection based on Acridinium ester (AE) ABEI
Throughput (up to) 150 t/h 200 t/h
Assay time approx. 30 min 17 min
Reagent positions 20 refrigerated 20
Sample positions 50 72
STAT positions (Emergency samples) 50 yes
Reaction cuvettes onboard capacity 1000 cuvettes 182 cuvettes
Cuvette format Single cuvettes in bulk format Cuvettes on plates

*All information is correct as of March 2024

 

 

Selecting the right immunoassay analyzer can significantly enhance laboratory efficiency and accuracy. This comparison between the HUMAN HumaCLIA 150 and SNIBE Maglumi X3 highlights their key features to help you decide which one best meets your laboratory needs.

Detection based on

The detection method used in immunoassay analyzers significantly affects the sensitivity and specificity of the tests, impacting the accuracy and reliability of results.

  • HumaCLIA 150: Utilizes Acridinium ester (AE), a chemiluminescent substrate known for its high sensitivity and specificity. AE detection works by labeling target molecules with acridinium esters, which emit light when triggered by a chemical reaction. This high-intensity light emission allows for precise and accurate measurement of low-abundance analytes, making it suitable for a wide range of assays.
  • Maglumi X3: Uses Acridinium ester-based immunoassay (ABEI), which also provides high sensitivity and robust performance across various tests. ABEI detection involves the use of acridinium esters in immunoassays, where the esters generate a chemiluminescent signal upon oxidation. This method ensures high sensitivity and specificity, similar to AE, and is effective for various clinical applications.

Throughput (up to)

Throughput capacity is crucial for laboratories with high sample volumes, as it determines the number of tests processed per hour, impacting overall efficiency and productivity.

  • HumaCLIA 150: Offers a maximum throughput of 150 tests per hour, ideal for high-volume testing environments.
  • Maglumi X3: Provides a higher throughput of 200 tests per hour, making it suitable for very high-volume laboratories.

Assay time

Assay time influences the speed at which individual tests are completed, affecting the turnaround time for results and overall laboratory workflow.

  • HumaCLIA 150: Has an approximate assay time of 30 minutes, providing a balance between rapid processing and detailed analysis.
  • Maglumi X3: Features a shorter assay time of approximately 17 minutes, allowing for quicker results and enhanced throughput.

Reagent positions

The number of reagent positions is critical for laboratories conducting diverse tests, as it determines how many different assays can be run without frequent reagent changes.

  • HumaCLIA 150: Equipped with 20 refrigerated reagent positions, supporting a wide range of tests and minimizing reagent change frequency.
  • Maglumi X3: Also offers 20 reagent positions, matching the capacity of HumaCLIA 150 for diverse testing needs.

Sample positions

Adequate sample positions are essential for managing sample volumes effectively, preventing backlogs, and ensuring smooth laboratory operations.

  • HumaCLIA 150: Provides 50 sample positions, catering to higher sample volumes and including provisions for urgent STAT samples.
  • Maglumi X3: Offers 72 sample positions, significantly higher than HumaCLIA 150, accommodating larger sample volumes and enhancing operational efficiency.

STAT positions (Emergency samples)

Efficient handling of STAT (emergency) samples is vital for clinical laboratories, ensuring priority processing without disrupting routine workflows.

  • HumaCLIA 150: Integrates STAT sample handling within its 50 sample positions, allowing for seamless inclusion of urgent tests.
  • Maglumi X3: Includes dedicated STAT sample handling capabilities, ensuring prompt processing of emergency samples.

Reaction cuvettes onboard capacity

Onboard cuvette capacity is essential for ensuring the analyzer can handle a high number of reactions without frequent interruptions for reloading, thus supporting continuous and efficient workflow.

  • HumaCLIA 150: Has a capacity of 1000 cuvettes, supporting high-throughput operations.
  • Maglumi X3: Provides a capacity of 182 cuvettes, which is lower than HumaCLIA 150 and may require more frequent reloading.

Cuvette format

The format of the cuvettes impacts ease of handling and loading efficiency. This feature is vital for maintaining smooth operations and reducing the time needed for manual interventions.

  • HumaCLIA 150: Uses single cuvettes in bulk format, which facilitates easy handling and loading, contributing to efficient laboratory workflow.
  • Maglumi X3: Utilizes cuvettes on plates, which can streamline the process but may require more handling compared to single cuvettes in bulk format.

Conclusion

The choice between the HumaCLIA 150 and Maglumi X3 should be based on the specific priorities and requirements of your laboratory. Considerations include testing volume, reagent and sample capacity, STAT sample handling, assay time, and cuvette management. By evaluating these factors, laboratories can make a well-informed decision that aligns with their operational needs and testing demands.

 

Use the following form for any request whether it is product related or concerning potential distribution partnership.
Fields marked with a * are mandatory. Please take care in entering all data correctly.